The aim of the study was to assess the level of cytokines in newborn children of various gestational ages with seizures. A prospective, comprehensive study of 307 newborns of various gestational ages with seizures was carried out. Changes in immunological reactivity in newborns with seizures are manifested in an abnormality of the cytokine status and a significant increase in pro-inflammatory cytokines (IL-1β by 1.9; IL-6 by 3 times; TNF-α by 3.3 times) in relation to newborns of the control group. The increased concentration of pro-inflammatory cytokines in newborns with HIE leads to the maintenance of seizure activity and aggravates further unfavorable neurological outcome. It was revealed that cerebral disorders and dysfunction of a number of organs and systems are correlated with the parameters of the immune systemin neonatal seizures. Thus, the expression of pro-inflammatory cytokines can be used as a screening marker in the diagnosis and prediction of neonatal seizures on the background of perinatal hypoxic - ischemic lesions of the central nervous system.
Boylan G, Stevenson N, Vabhatalo S. Monitoring neonatal seizures. Seminars in Fetal & Neonatal Medicine 2013,18, рр.202-208.
Hart A, Pilling E, Alix J. Neonatal seizures—part 1: Not everything that jerks, stiffens and shakes is a fit. Arch Dis Child EducPract Ed 2015,100, рр.170-175.
Jensen F, Silverstein F. Neonatal seizures. In: Swaiman's Pediatric Neurology: Principles and Practice 5th edition [Internet]. In: Swaiman K, Ashwal S, Ferriero DM, NF S, editors. Edinburgh: Elsevier; 2012 [Cited 2016 Aug 15]. . Available from: ClinicalKey Australia.
Sivaswamy L. Approach to neonatal seizures. Clinical Pediatrics 2012, 51(5), рр. 415-425.
Cilio M. Neonatal epilepsies and epileptic encephalopathies. In: Nagarajan, L editor. Neonatal Seizures: Current Treatment and Future Challenges. London: Mac Keith Press; 2016.
Glass H, Shellhaas R, Wusthoff C, Chang T, Abend N, Chu C, et al. Contemporary Profile of Seizures in Neonates: A Prospective Cohort Study. J Pediatr 2016,174, рр.98-103.
Айкарди Ж., Бакс М., Гиллберг К. Заболевания нервной системы у детей. Пер. сангл.; подред.А.А.Скоромца М.2013.-1036 с.
Галашева З.В., Поскотинова Л.В. Роль интерлейкина-6 и интерлейкина-10 в функцио-нировании НС. // Вестник САФУ. Сер.: «Медико-биологические науки». 2016. - № 3. - С. 5–17.
Чистякова Г.Н., Ремизова И.И., Газиева И.А., Бычкова С.В., Занина Е.В., Чарипова Б.Т. Про- и противовоспалительные медиаторы у новорожденных с перинатальной патологией // Российский вестник перинатологии и педиатрии. -2014.-2.- С.6-70.
Lisyany NI, Znamenska TK, MartyniukVYu, Shveikina VB. (2019). To the question of neuroimmune mechanisms in the formation of perinatal brain damage. Modern Pediatrics.Ukraine. 6(102), р. 7289. doi 10.15574/SP.2019.102.72
Hermandez-Ontiveros D.G., Tajiri N., Acosta S., Giunta B., Tan J., Borlongan C.V. Micro-glia activation as a biomarker for traumatic brain injury. Front. Neurol., 2013, Vol. 4, 30,pp. 1-9.
Aly H, Khashaba MT, El-Ayouty M, et al. IL-1beta, IL-6 and TNF-alpha and outcomes of neonatal hypoxic ischemic encephalopathy. Brain Dev. 2006,28:3, рр.178-182. doi: 10.1016/j.braindev.2005.06.006.
Arimoto T, Choi DY, Lu X, et al. Interleukin-10 protects against inflammation-mediated degeneration of dopaminergic neurons in substantianigra. Neurobiol Aging. 2007, 28(6), рр.894-906. doi:10.1016/j.neurobiolaging.2006.04.011.
Гараев В.Р. Нейроиммунологические показатели поста ноксической энцефалопатии новорожденных и прогноз психоневрологических последствий. Автореферат на соиск. Ученой степени канд. мед.наук. Санкт-Петербург 2013. - 22с.
Sävman K, Blennow M, Hagberg H, et al. Cytokine response in cerebrospinal fluid from preterm infants with posthaemorrhagic ventricular dilatation. Acta Paediatr. 2007, 91(12),рр. 1357-1363. doi: 10.1111/ j.1651-2227.2002.tb02834.x.